Literature DB >> 33020878

Mark Oette1.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 33020878      PMCID： PMC7535079          DOI： 10.1007/s15006-020-3450-8

Source DB:  PubMed          Journal:  MMW Fortschr Med        ISSN： 1438-3276


× No keyword cloud information.
  11 in total

1.  Clinical characteristics of COVID-19 and its comparison with influenza pneumonia.

Authors:  Jiajia Qu; Lap Kam Chang; Xinghua Tang; Yiming Du; Xi Yang; Xiangjiao Liu; Ping Han; Yuwen Xue
Journal:  Acta Clin Belg       Date:  2020-07-29       Impact factor: 1.264

2.  The Characteristics of 50 Hospitalized COVID-19 Patients With and Without ARDS.

Authors:  Michael Dreher; Alexander Kersten; Johannes Bickenbach; Paul Balfanz; Bojan Hartmann; Christian Cornelissen; Ayham Daher; Robert Stöhr; Michael Kleines; Sebastian W Lemmen; Jörg Christian Brokmann; Tobias Müller; Dirk Müller-Wieland; Gernot Marx; Nikolaus Marx
Journal:  Dtsch Arztebl Int       Date:  2020-04-17       Impact factor: 5.594

3.  Risk of Ischemic Stroke in Patients With Coronavirus Disease 2019 (COVID-19) vs Patients With Influenza.

Authors:  Alexander E Merkler; Neal S Parikh; Saad Mir; Ajay Gupta; Hooman Kamel; Eaton Lin; Joshua Lantos; Edward J Schenck; Parag Goyal; Samuel S Bruce; Joshua Kahan; Kelsey N Lansdale; Natalie M LeMoss; Santosh B Murthy; Philip E Stieg; Matthew E Fink; Costantino Iadecola; Alan Z Segal; Marika Cusick; Thomas R Campion; Ivan Diaz; Cenai Zhang; Babak B Navi
Journal:  JAMA Neurol       Date:  2020-07-02       Impact factor: 18.302

Review 4.  Influenza.

Authors:  Sam Ghebrehewet; Peter MacPherson; Antonia Ho
Journal:  BMJ       Date:  2016-12-07

Review 5.  Heterogeneous and Dynamic Prevalence of Asymptomatic Influenza Virus Infections.

Authors:  Luis Furuya-Kanamori; Mitchell Cox; Gabriel J Milinovich; Ricardo J Soares Magalhaes; Ian M Mackay; Laith Yakob
Journal:  Emerg Infect Dis       Date:  2016-06       Impact factor: 6.883

Review 6.  Does this patient have COVID-19? A practical guide for the internist.

Authors:  Lorenzo Bertolino; Martina Vitrone; Emanuele Durante-Mangoni
Journal:  Intern Emerg Med       Date:  2020-05-23       Impact factor: 5.472

7.  Decreased Influenza Incidence under COVID-19 Control Measures, Singapore.

Authors:  Roy Jiunn Jye Soo; Calvin J Chiew; Stefan Ma; Rachael Pung; Vernon Lee
Journal:  Emerg Infect Dis       Date:  2020-04-27       Impact factor: 6.883

8.  The many estimates of the COVID-19 case fatality rate.

Authors:  Dimple D Rajgor; Meng Har Lee; Sophia Archuleta; Natasha Bagdasarian; Swee Chye Quek
Journal:  Lancet Infect Dis       Date:  2020-03-27       Impact factor: 25.071

9.  Comparison of Hospitalized Patients With ARDS Caused by COVID-19 and H1N1.

Authors:  Xiao Tang; Rong-Hui Du; Rui Wang; Tan-Ze Cao; Lu-Lu Guan; Cheng-Qing Yang; Qi Zhu; Ming Hu; Xu-Yan Li; Ying Li; Li-Rong Liang; Zhao-Hui Tong; Bing Sun; Peng Peng; Huan-Zhong Shi
Journal:  Chest       Date:  2020-03-26       Impact factor: 9.410

10.  COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study.

Authors:  Marina Chiara Garassino; Jennifer G Whisenant; Li-Ching Huang; Annalisa Trama; Valter Torri; Francesco Agustoni; Javier Baena; Giuseppe Banna; Rossana Berardi; Anna Cecilia Bettini; Emilio Bria; Matteo Brighenti; Jacques Cadranel; Alessandro De Toma; Claudio Chini; Alessio Cortellini; Enriqueta Felip; Giovanna Finocchiaro; Pilar Garrido; Carlo Genova; Raffaele Giusti; Vanesa Gregorc; Francesco Grossi; Federica Grosso; Salvatore Intagliata; Nicla La Verde; Stephen V Liu; Julien Mazieres; Edoardo Mercadante; Olivier Michielin; Gabriele Minuti; Denis Moro-Sibilot; Giulia Pasello; Antonio Passaro; Vieri Scotti; Piergiorgio Solli; Elisa Stroppa; Marcello Tiseo; Giuseppe Viscardi; Luca Voltolini; Yi-Long Wu; Silvia Zai; Vera Pancaldi; Anne-Marie Dingemans; Jan Van Meerbeeck; Fabrice Barlesi; Heather Wakelee; Solange Peters; Leora Horn
Journal:  Lancet Oncol       Date:  2020-06-12       Impact factor: 41.316
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.